Login to Your Account



What a GEM: PTC Inks GEMS Drug Discovery Deal with AZ

By Trista Morrison


Thursday, June 30, 2011
While continuing to advance its internal pipeline, PTC Therapeutics Inc. signed yet another big pharma partnership for its Gene Expression Modulation by Small-molecules (GEMS) drug discovery platform.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription